Screening of small molecules that selectively kill SUCLA2-deleted... | Download Scientific Diagram
Targeting metabolic vulnerability in advanced prostate cancer | Cancer Community
Clinical and molecular features of mitochondrial DNA depletion syndromes - Spinazzola - 2009 - Journal of Inherited Metabolic Disease - Wiley Online Library
PDF) SUCLA2 mutations are associated with mild methylmalonic aciduria, Leigh-like encephalomyopathy, dystonia and deafness
Anti-SUCLA2 antibody (GTX64854) | GeneTex
SUCLA2 Fusion Protein Ag3319 | Proteintech
SUCLA2 gene | Semantic Scholar
Advanced prostate cancer has an unexpected we | EurekAlert!
Dystonia and deafness due to SUCLA2 defect; Clinical course and biochemical markers in 16 children - ScienceDirect
SUCLA2 CRISPR Knockout and Activation Products (m) | SCBT - Santa Cruz Biotechnology